These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9815719)

  • 41. Resection of hepatic metastasis after 5-fluorouracil and cofactor for colon cancer.
    Costantini CL; Reid TR; Bouvet M
    Hepatogastroenterology; 2009; 56(91-92):645-9. PubMed ID: 19621672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
    Trocha SD; Saha SS; Wiese D; Thompson J; Morton DL; Bilchik AJ
    Am Surg; 2003 Oct; 69(10):918-22. PubMed ID: 14570375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thymidylate synthase expression predicts the response to 5-fluorouracil-based adjuvant therapy in pancreatic cancer.
    Hu YC; Komorowski RA; Graewin S; Hostetter G; Kallioniemi OP; Pitt HA; Ahrendt SA
    Clin Cancer Res; 2003 Sep; 9(11):4165-71. PubMed ID: 14519641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Kitajima M; Takechi T; Okabe H; Fukushima M
    Clin Cancer Res; 1999 Apr; 5(4):883-9. PubMed ID: 10213225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
    Anticancer Res; 1999; 19(6C):5635-40. PubMed ID: 10697632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
    Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
    Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.
    Spears CP; Gustavsson BG; Mitchell MS; Spicer D; Berne M; Bernstein L; Danenberg PV
    Cancer Res; 1984 Sep; 44(9):4144-50. PubMed ID: 6744325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites.
    Johnston PG; Benson AB; Catalano P; Rao MS; O'Dwyer PJ; Allegra CJ
    J Clin Oncol; 2003 Mar; 21(5):815-9. PubMed ID: 12610179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
    Johnston PG; Drake JC; Trepel J; Allegra CJ
    Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Response prediction in metastasised colorectal cancer using intratumoural thymidylate synthase: results of a randomised multicentre trial.
    Kornmann M; Hebart H; Danenberg K; Goeb R; Staib L; Kron M; Henne-Bruns D; Danenberg P; Link KH
    Eur J Cancer; 2012 Jul; 48(10):1443-51. PubMed ID: 22133572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase.
    Hanlon MH; Ferone R
    Cancer Res; 1996 Jul; 56(14):3301-6. PubMed ID: 8764125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy.
    Aschele C; Debernardis D; Casazza S; Antonelli G; Tunesi G; Baldo C; Lionetto R; Maley F; Sobrero A
    J Clin Oncol; 1999 Jun; 17(6):1760-70. PubMed ID: 10561213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
    Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA
    Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time course of inhibition of thymidylate synthase in patients treated with fluorouracil and leucovorin.
    Peters GJ; van Groeningen CJ; van der Wilt CL; Meijer S; Smid K; Laurensse E; Pinedo HM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):26-35. PubMed ID: 1557655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of thymidylate synthase expression in resected metastases of colorectal cancer.
    Corsi DC; Ciaparrone M; Zannoni G; Mancini M; Cassano A; Specchia M; Pozzo C; Martini M; Barone C
    Eur J Cancer; 2002 Mar; 38(4):527-34. PubMed ID: 11872345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy.
    Lim L; Gibbs P; Yip D; Shapiro JD; Dowling R; Smith D; Little A; Bailey W; Liechtenstein M
    BMC Cancer; 2005 Oct; 5():132. PubMed ID: 16225697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacological and biochemical investigation of intracavital fluorinated pyrimidine chemotherapy].
    Shibata H; Aiba K; Mihara H; Ito Y; Takahashi S; Horikoshi N; Kasumi F; Ohta H; Takahashi T
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1613-5. PubMed ID: 7574773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thymidylate synthase pharmacogenetics in colorectal cancer.
    Marsh S; McLeod HL
    Clin Colorectal Cancer; 2001 Nov; 1(3):175-8; discussion 179-81. PubMed ID: 12450432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.